Nanofibrous Vildagliptin-Eluting Stents Enhance Re-Endothelialization And Reduce Neointimal Formation In Diabetes: In Vitro And In Vivo [Corrigendum]
Lee CH, Hsieh MJ, Chang SH, et al. Int J Nano. 2019;14:7503–7513. The authors noticed a mistake in the published paper which was overlooked during the revision stages. On page 7511, in the Acknowledgments section, the sentence “… Chang Gung M...
Main Authors: | , , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2019-12-01
|
Series: | International Journal of Nanomedicine |
Online Access: | https://www.dovepress.com/httpswwwdovepresscomcorrigendum-nanofibrous-vildagliptin-eluting-stent-peer-reviewed-article-IJN |
id |
doaj-4362d81c770a46c4901c73455604f282 |
---|---|
record_format |
Article |
spelling |
doaj-4362d81c770a46c4901c73455604f2822020-11-25T02:28:48ZengDove Medical PressInternational Journal of Nanomedicine1178-20132019-12-01Volume 149793979450390Nanofibrous Vildagliptin-Eluting Stents Enhance Re-Endothelialization And Reduce Neointimal Formation In Diabetes: In Vitro And In Vivo [Corrigendum]Lee CHHsieh MJChang SHHung KCWang CJHsu MYJuang JHHsieh ICWen MSLiu SJLee CH, Hsieh MJ, Chang SH, et al. Int J Nano. 2019;14:7503–7513. The authors noticed a mistake in the published paper which was overlooked during the revision stages. On page 7511, in the Acknowledgments section, the sentence “… Chang Gung Memorial Hospital (Contract No. CMRPG3G1291) for financially supporting this research.” should read “… Chang Gung Memorial Hospital (Contract No. CMRPG3G1291 and CMRPG3G1292) for financially supporting this research.” The authors apologize for this oversight.Read the original articlehttps://www.dovepress.com/httpswwwdovepresscomcorrigendum-nanofibrous-vildagliptin-eluting-stent-peer-reviewed-article-IJN |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Lee CH Hsieh MJ Chang SH Hung KC Wang CJ Hsu MY Juang JH Hsieh IC Wen MS Liu SJ |
spellingShingle |
Lee CH Hsieh MJ Chang SH Hung KC Wang CJ Hsu MY Juang JH Hsieh IC Wen MS Liu SJ Nanofibrous Vildagliptin-Eluting Stents Enhance Re-Endothelialization And Reduce Neointimal Formation In Diabetes: In Vitro And In Vivo [Corrigendum] International Journal of Nanomedicine |
author_facet |
Lee CH Hsieh MJ Chang SH Hung KC Wang CJ Hsu MY Juang JH Hsieh IC Wen MS Liu SJ |
author_sort |
Lee CH |
title |
Nanofibrous Vildagliptin-Eluting Stents Enhance Re-Endothelialization And Reduce Neointimal Formation In Diabetes: In Vitro And In Vivo [Corrigendum] |
title_short |
Nanofibrous Vildagliptin-Eluting Stents Enhance Re-Endothelialization And Reduce Neointimal Formation In Diabetes: In Vitro And In Vivo [Corrigendum] |
title_full |
Nanofibrous Vildagliptin-Eluting Stents Enhance Re-Endothelialization And Reduce Neointimal Formation In Diabetes: In Vitro And In Vivo [Corrigendum] |
title_fullStr |
Nanofibrous Vildagliptin-Eluting Stents Enhance Re-Endothelialization And Reduce Neointimal Formation In Diabetes: In Vitro And In Vivo [Corrigendum] |
title_full_unstemmed |
Nanofibrous Vildagliptin-Eluting Stents Enhance Re-Endothelialization And Reduce Neointimal Formation In Diabetes: In Vitro And In Vivo [Corrigendum] |
title_sort |
nanofibrous vildagliptin-eluting stents enhance re-endothelialization and reduce neointimal formation in diabetes: in vitro and in vivo [corrigendum] |
publisher |
Dove Medical Press |
series |
International Journal of Nanomedicine |
issn |
1178-2013 |
publishDate |
2019-12-01 |
description |
Lee CH, Hsieh MJ, Chang SH, et al. Int J Nano. 2019;14:7503–7513.
The authors noticed a mistake in the published paper which was overlooked during the revision stages.
On page 7511, in the Acknowledgments section, the sentence “… Chang Gung Memorial Hospital (Contract No. CMRPG3G1291) for financially supporting this research.” should read “… Chang Gung Memorial Hospital (Contract No. CMRPG3G1291 and CMRPG3G1292) for financially supporting this research.”
The authors apologize for this oversight.Read the original article |
url |
https://www.dovepress.com/httpswwwdovepresscomcorrigendum-nanofibrous-vildagliptin-eluting-stent-peer-reviewed-article-IJN |
work_keys_str_mv |
AT leech nanofibrousvildagliptinelutingstentsenhancereendothelializationandreduceneointimalformationindiabetesinvitroandinvivocorrigendum AT hsiehmj nanofibrousvildagliptinelutingstentsenhancereendothelializationandreduceneointimalformationindiabetesinvitroandinvivocorrigendum AT changsh nanofibrousvildagliptinelutingstentsenhancereendothelializationandreduceneointimalformationindiabetesinvitroandinvivocorrigendum AT hungkc nanofibrousvildagliptinelutingstentsenhancereendothelializationandreduceneointimalformationindiabetesinvitroandinvivocorrigendum AT wangcj nanofibrousvildagliptinelutingstentsenhancereendothelializationandreduceneointimalformationindiabetesinvitroandinvivocorrigendum AT hsumy nanofibrousvildagliptinelutingstentsenhancereendothelializationandreduceneointimalformationindiabetesinvitroandinvivocorrigendum AT juangjh nanofibrousvildagliptinelutingstentsenhancereendothelializationandreduceneointimalformationindiabetesinvitroandinvivocorrigendum AT hsiehic nanofibrousvildagliptinelutingstentsenhancereendothelializationandreduceneointimalformationindiabetesinvitroandinvivocorrigendum AT wenms nanofibrousvildagliptinelutingstentsenhancereendothelializationandreduceneointimalformationindiabetesinvitroandinvivocorrigendum AT liusj nanofibrousvildagliptinelutingstentsenhancereendothelializationandreduceneointimalformationindiabetesinvitroandinvivocorrigendum |
_version_ |
1724836309726396416 |